Infographics - Stem Cell Cartilage Regeneration Market

In cartilage regeneration, stem cells have the potential for multiple differentiation and self-replication, making them an ideal choice for use as seed cells. The growing regenerative medicine industry and increasing demand for stem cells in the development of various types of cell therapies are expected to drive the growth of the market over the forecast period. Mesenchymal stem cells are the most widely applied stem cells in the field of cartilage regeneration. Furthermore, adult stem cells have the potential to differentiate into cartilage, bone, fat or soft tissue. Stem cell-based therapy has become a key focus in the functional replacement of cartilage regeneration. Adult stem cells can be extracted by minimally invasive methods from fat tissue and bone marrow. Fat-derived stem cells exhibit an enhanced ability to differentiate into cartilage and are found in higher numbers than bone marrow.

Market Dynamics

Increasing research and development activities is expected to drive the market over the forecast period for instance, in August 2020, data was published in the Stanford Medicine journal, according to that, researchers at the Stanford University School of Medicine have discovered a way to regenerate, in mice and human tissue, the cushion of cartilage found in joints. The Stanford researchers figured out how to regrow articular cartilage by first causing slight injury to the joint tissue, then using chemical signals to steer the growth of skeletal stem cells as the injuries heal.

Key features of the study:

This report provides an in-depth analysis of the global stem cell cartilage regeneration market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global stem cell cartilage regeneration market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation. Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global stem cell cartilage regeneration market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell cartilage regeneration market

Detailed Segmentation:

Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type :
- Hematopoietic Stem Cells (HSCs)
- Pluripotent Stem Cells (iPSC/ESCs)
- Mesenchymal Stem Cells (MSCs)
Global Stem Cell Cartilage Regeneration Market, By Treatment:
- Microfracture
- Osteochondral Transplant
- Autologous Chondrocyte Implantation
- Stem Cell Injections
Global Stem Cell Cartilage Regeneration Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
Global Stem Cell Cartilage Regeneration Market, By Region:
- North America
  - By Country:
    - U.S.
    - Canada
- Latin America
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Country:
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Country:
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Country/Region:
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- Theracell Advanced Biotechnology Ltd *
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Orthocell Ltd.
- Xintela AB
- CellGenix GmbH
- Merck KGaA
- Osiris Therapeutics, Inc.
- BioTissue SA
- Vericel Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Stem Cell Type
  - Market Snapshot, By Treatment
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
  - Impact Analysis
  - Key Highlights
  - Product Launch
  - Technological Advancements
  - PEST Analysis
  - Regulatory Scenario
  - Mergers and Acquisitions
Global Stem Cell Cartilage Regeneration Market - Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type, 2017 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Hematopoietic Stem Cells (HSCs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Pluripotent Stem Cells (iPSC/ESCs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Mesenchymal Stem Cells (MSCs)
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Global Stem Cell Cartilage Regeneration Market, By Treatment, 2017 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Microfracture
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Osteochondral Transplant
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Autologous Chondrocyte Implantation
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Stem Cell Injections
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)
Global Stem Cell Cartilage Regeneration Market, By End User, 2017 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-O-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Hospitals & Clinics
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2017–2030, (US$) Million)
- Ambulatory Surgical Centers
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2017–2030, (US$) Million)
Global Stem Cell Cartilage Regeneration Market, By Region, 2017 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2017–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Theracell Advanced Biotechnology Ltd*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Orthocell Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Xintela AB
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CellGenix GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Osiris Therapeutics, Inc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- BioTissue SA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vericel Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 32 market data tables and 24 figures on “Global Stem Cell Cartilage Regeneration Market” - Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

STEM CELL CARTILAGE REGENERATION MARKET ANALYSIS

Stem Cell Cartilage Regeneration Market

Need a Custom Report?

EXISTING CLIENTELE